Histopathologic predictors of pilocytic astrocytoma event-free survival

被引:63
|
作者
Tibbetts, Kathleen M. [2 ]
Emnett, Ryan J. [2 ]
Gao, Feng [3 ]
Perry, Arie [4 ]
Gutmann, David H. [2 ]
Leonard, Jeffrey Russell [1 ]
机构
[1] Washington Univ, Sch Med, Dept Neurosurg, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA
[3] Washington Univ, Sch Med, Dept Biostat, St Louis, MO 63110 USA
[4] Washington Univ, Sch Med, Dept Pathol & Immunol, Div Neuropathol, St Louis, MO 63110 USA
关键词
Glioma; Pediatric; CD68; Microglia; Brain tumor; Pilocytic astrocytoma; Prognosis; EXPRESSION; CHILDREN; PROLIFERATION; PROGRESSION; MANAGEMENT; SUBSETS; TUMORS; INDEX; MIB-1;
D O I
10.1007/s00401-009-0506-3
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Pilocytic astrocytoma (PA) is the most common pediatric brain tumor. Most arise in the cerebellum, but they also can develop in the brainstem and optic nerve, where gross total resection (GTR) is not possible. In the absence of GTR, significant variability in both clinical behavior and histology exists. To identify potential markers associated with poor clinical outcome, we retrospectively assessed pathological features in 107 patients with PAs. We identified four pathological features (necrosis, oligodendroglioma-like features, vascular hyalinization, and calcification) that showed a significant correlation with decreased event-free survival (EFS). Similar to previous reports, we also found that PAs involving the optic pathway were associated with worse EFS compared with those arising in other locations. In contrast, mitotic index, p53 immunoreactivity and hyperactivation of several mitogenic signaling pathways (MAPK, CREB, mTOR) did not demonstrate a statistically significant relationship with EFS. Lastly, we did find a statistical trend between EFS and the number of CD68+ cells, suggesting that non-neoplastic elements of the tumor microenvironment may influence subsequent growth and clinical recurrence. Collectively, the identification of specific histopathologic features associated with clinical outcome may improve our ability to determine which PAs are more likely to exhibit clinical progression and require more vigilant observation.
引用
收藏
页码:657 / 665
页数:9
相关论文
共 50 条
  • [21] Addition of sintilimab to standard therapy improves event-free survival
    Sidaway, Peter
    NATURE REVIEWS CLINICAL ONCOLOGY, 2024, 21 (09) : 640 - 640
  • [22] PREDICTORS OF 6-YEAR EVENT-FREE SURVIVAL IN PATIENTS WITH ALAGILLE SYNDROME TREATED WITH MARALIXIBAT, AN IBAT INHIBITOR
    Sokol, Ronald J.
    Gonzales, Emmanuel M.
    Kamath, Binita M.
    Baker, Alastair
    Vig, Pamela
    Tucker, Ed
    Garner, Will
    Hansen, Bettina E.
    Jacquemin, Emmanuel
    Thompson, Richard J.
    HEPATOLOGY, 2021, 74 (06) : 1401A - 1402A
  • [23] A novel event-free survival endpoint in locally advanced pancreatic cancer
    Hammel, Pascal
    Carrier, Ewa
    Carney, Mairead
    Eisner, Mark
    Fleming, Thomas
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13
  • [24] Preemptive Bone Marrow Transplantation and Event-Free Survival in Fanconi Anemia
    Khan, Nicholas E.
    Rosenberg, Philip S.
    Alter, Blanche P.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (10) : 1888 - 1892
  • [25] Immunohistochemical expression of ezrin correlates with Event-free and overall survival in osteosarcomas
    Salas, S.
    Deville, J.
    Bartoli, C.
    Gaudart, J.
    Bollini, G.
    Curvale, G.
    Gentet, J.
    Duffaud, F.
    Figarella-Branger, D.
    Bouvier, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [26] Depressive Symptoms: Mediator of Event-Free Survival in Patients With Heart Failure
    Hammash, Muna H.
    Lennie, Terry A.
    Crawford, Timothy
    Heo, Seongkum
    Chung, Misook L.
    Biddle, Martha J.
    Dekker, Rebecca
    Wu, Jia-Rong
    Rayens, Mary Kay
    Moser, Debra K.
    WESTERN JOURNAL OF NURSING RESEARCH, 2017, 39 (04) : 539 - 552
  • [27] Event-Free Survival in Central Appalachian Implantable Cardioverter Defibrillator Recipients
    Miller, Jennifer L.
    Chung, Misook L.
    Hammash, Muna
    Harman, Jessica L.
    Haedtke, Christine
    Elayi, Samy Claude
    Czarapata, Mary M.
    Biddle, Martha J.
    Moser, Debra K.
    CIRCULATION, 2017, 136
  • [28] Germline Variation in Complement Genes and Event-Free Survival in Follicular Lymphoma
    Cerhan, James R.
    Maurer, Matthew J.
    Novak, Anne J.
    Ansell, Stephen M.
    Macon, William R.
    Slager, Susan L.
    Weiner, George J.
    Witzig, Thomas E.
    Habermann, Thomas M.
    BLOOD, 2009, 114 (22) : 183 - 183
  • [29] Effect of total treatment time on event-free survival in carcinoma of the cervix
    Delaloye, JF
    Coucke, PA
    Pampallona, S
    DeGrandi, P
    GYNECOLOGIC ONCOLOGY, 1996, 60 (01) : 42 - 48
  • [30] High OPCAB Surgical Volume Improves Midterm Event-Free Survival
    Agostini, Marco
    Fino, Carlo
    Torchio, Pierfederico
    Di Gregorio, Vincenzo
    Feola, Mauro
    Bertora, Marco
    Lugli, Elisa
    Grossi, Claudio
    HEART SURGERY FORUM, 2009, 12 (05): : E250 - E255